IRS1 and neoplasm: Also under serum depletion with addition of exogenous IGF-1 IRS-1 showed decreased phosphorylation in cells treated with compounds 1 and 2 albeit of less magnitude than when cells were cultured in serum, which was the condition where we found these compounds to have specific anti-tumor activity.